FDA
-
-
-
-
-
-
-
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
-
-
-
-
-
-
-
Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine
-
-
-
-
-
-
-
Elixir Launches Specialty Generic Enhancement that Leads to Thousands in Annual Savings for Plan Sponsors and Members
-
-
-
-
-
-
-
Rite Aid (RAD) Prepared to Start Administering COVID-19 Vaccine for Children Ages 5-11
-
-
-
-
-
-
-
Rite Aid (RAD) to Hire 5,000 Associates and Expand COVID-19 Activities
-
-
-
-
-
-
-
FDA investigating whether Zantac causes carcinogens to form in users
-
-
-
-
-
-
-
Rite Aid Makes Free Opioid Disposal Solution Available At More Than 2,500 Pharmacies Nationwide
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

